A protecting group-free synthesis of deazathiamine: A step toward inhibitor design Journal Article


Authors: Zhao, H.; de Carvalho, L. P. S.; Nathan, C.; Ouerfelli, O.
Article Title: A protecting group-free synthesis of deazathiamine: A step toward inhibitor design
Abstract: The discovery of 3-deazathiamine diphosphate (deazaThDP) as a potent inhibitor analog of the cofactor thiamine diphosphate (ThDP) has highlighted the need for an efficient and scalable synthesis of deazaThDP. Such a method would facilitate development of analogs with the ability to inhibit individual ThDP-dependent enzymes selectively. Toward the goal of developing selective inhibitors of the mycobacterial enzyme 2-hydroxy-3-oxoadipate synthase (HOAS), we report an improved synthesis of deazaThDP without use of protecting groups. Tribromo-3-methylthiophene served as a versatile starting material whose selective functionalization permitted access to deazaThDP in five steps, with potential to make other analogs accessible in substantial amounts. © 2010 Elsevier Ltd. All rights reserved.
Keywords: unclassified drug; drug structure; in vitro study; drug synthesis; antiinfective agent; ic 50; pyrimidine; carbon nuclear magnetic resonance; 2 hydroxy 3 oxoadipate synthase; bacterial enzyme; antimicrobial activity; 2,3,5-tribromo-3-methylthiophene; 3-deazathiamine; 3-deazathiamine synthesis; 3-deazathiaminediphosphate; deazathiamine; 3 deazathiamine; 3 deazathiamine diphosphate
Journal Title: Bioorganic & Medicinal Chemistry Letters
Volume: 20
Issue: 22
ISSN: 0960-894X
Publisher: Pergamon-Elsevier Science Ltd  
Date Published: 2010-11-15
Start Page: 6472
End Page: 6474
Language: English
DOI: 10.1016/j.bmcl.2010.09.053
PROVIDER: scopus
PUBMED: 20943392
PMCID: PMC2957563
DOI/URL:
Notes: --- - "Export Date: 20 April 2011" - "CODEN: BMCLE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ouathek Ouerfelli
    100 Ouerfelli
  2. Hong Zhao
    5 Zhao